Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway

Cannabinoid compounds have potential as treatments for a variety of conditions, with cannabigerol (CBG) being known for its anti-inflammatory properties. In this study, we investigated the effects of CBG in a cellular model of 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis (AD). In the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ga Hee Jeong, Ki Chan Kim, Ji Hyun Lee
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/2/83
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588834226831360
author Ga Hee Jeong
Ki Chan Kim
Ji Hyun Lee
author_facet Ga Hee Jeong
Ki Chan Kim
Ji Hyun Lee
author_sort Ga Hee Jeong
collection DOAJ
description Cannabinoid compounds have potential as treatments for a variety of conditions, with cannabigerol (CBG) being known for its anti-inflammatory properties. In this study, we investigated the effects of CBG in a cellular model of 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis (AD). In the cellular model, we confirmed the cytotoxicity of CBG and downregulated the expression of inflammatory markers <i>CCL26</i>, <i>IL1B</i>, <i>IL6</i>, and <i>TNF</i> (<i>p</i> < 0.001). In the mouse model, clinical, histological, and immunological changes were analyzed. The results showed that CBG improved dermatitis severity score, epidermal thickness, and mast cell count and reduced inflammatory cytokines (<i>Tslp</i>, <i>Il1b</i>, <i>Il4</i>, <i>Il6</i>, <i>Il13</i>, <i>Il17</i>, <i>Il18</i>, <i>Il22</i>, and <i>Il33</i>) by qRT-PCR (<i>p</i> < 0.001). Western blot results showed modulated changes in JAK1, JAK2, TYK2, STAT1, STAT2, STAT3, p-STAT3, STAT6, and p-STAT6 (<i>p</i> < 0.05). Subsequently, p-IκBα, NF-κB, and p-NF-κB signaling factors were also reduced (<i>p</i> < 0.05), with corresponding changes in skin barrier factors. The results of this study indicate that CBG effectively alleviates AD-like symptoms and suggest the potential of CBG as a therapeutic agent.
format Article
id doaj-art-4c094e3e300b42a58cb4714d85c33621
institution Kabale University
issn 2073-4409
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-4c094e3e300b42a58cb4714d85c336212025-01-24T13:26:36ZengMDPI AGCells2073-44092025-01-011428310.3390/cells14020083Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling PathwayGa Hee Jeong0Ki Chan Kim1Ji Hyun Lee2Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of KoreaDepartment of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of KoreaDepartment of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of KoreaCannabinoid compounds have potential as treatments for a variety of conditions, with cannabigerol (CBG) being known for its anti-inflammatory properties. In this study, we investigated the effects of CBG in a cellular model of 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis (AD). In the cellular model, we confirmed the cytotoxicity of CBG and downregulated the expression of inflammatory markers <i>CCL26</i>, <i>IL1B</i>, <i>IL6</i>, and <i>TNF</i> (<i>p</i> < 0.001). In the mouse model, clinical, histological, and immunological changes were analyzed. The results showed that CBG improved dermatitis severity score, epidermal thickness, and mast cell count and reduced inflammatory cytokines (<i>Tslp</i>, <i>Il1b</i>, <i>Il4</i>, <i>Il6</i>, <i>Il13</i>, <i>Il17</i>, <i>Il18</i>, <i>Il22</i>, and <i>Il33</i>) by qRT-PCR (<i>p</i> < 0.001). Western blot results showed modulated changes in JAK1, JAK2, TYK2, STAT1, STAT2, STAT3, p-STAT3, STAT6, and p-STAT6 (<i>p</i> < 0.05). Subsequently, p-IκBα, NF-κB, and p-NF-κB signaling factors were also reduced (<i>p</i> < 0.05), with corresponding changes in skin barrier factors. The results of this study indicate that CBG effectively alleviates AD-like symptoms and suggest the potential of CBG as a therapeutic agent.https://www.mdpi.com/2073-4409/14/2/83cannabigerolJanus kinase-signal transducer and activator of transcriptionatopic dermatitis
spellingShingle Ga Hee Jeong
Ki Chan Kim
Ji Hyun Lee
Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
Cells
cannabigerol
Janus kinase-signal transducer and activator of transcription
atopic dermatitis
title Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
title_full Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
title_fullStr Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
title_full_unstemmed Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
title_short Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
title_sort anti inflammatory effects of cannabigerol in vitro and in vivo are mediated through the jak stat nfκb signaling pathway
topic cannabigerol
Janus kinase-signal transducer and activator of transcription
atopic dermatitis
url https://www.mdpi.com/2073-4409/14/2/83
work_keys_str_mv AT gaheejeong antiinflammatoryeffectsofcannabigerolinvitroandinvivoaremediatedthroughthejakstatnfkbsignalingpathway
AT kichankim antiinflammatoryeffectsofcannabigerolinvitroandinvivoaremediatedthroughthejakstatnfkbsignalingpathway
AT jihyunlee antiinflammatoryeffectsofcannabigerolinvitroandinvivoaremediatedthroughthejakstatnfkbsignalingpathway